OncoRes Medical’s Post

🔬 International Clinical Trials Day   OncoRes Medical is marking International Clinical Trials Day today.   Quick fact > International Clinical Trials Day is celebrated globally on 20 May to commemorate when Scottish Surgeon James Lind commenced what is recognised as the first ever randomised clinical trial in scurvy in 1747, laying the foundations for modern clinical research.   277+ years later, clinical research remains an important part of the global economy and healthcare system. For our growing business, it is vital – we are developing technology (QME – Quantitative Micro-Elastography) to change the way surgeons perform cancer surgery, supercharging the surgeons’ sense of touch. We are starting in Breast Cancer, where up to a third of patients need two or more invasive surgeries to remove all of the cancer.   Our device is currently in clinical trials to test its merits in practice. So far, we have completed three clinical trials at Fiona Stanley Hospital in Western Australia; and a multisite trial has just commenced at the Peter MacCallum Cancer Centre and The Royal Melbourne Hospital in Victoria, and Fiona Stanley Hospital and Fremantle Hospital in Western Australia.   These trials have supported development of our product and will support applications to the TGA and FDA. They have many moving parts – but the end goal is so worth it. Measured, ethical innovation, with the capacity to bring incredible, patient-first innovation to the operating table.   #clinicaltrials #oncology # medtech #innovation #breastcancer #breastconservation #breastconservationsurgery #lumpectomy #patientsfirst #patientoutcomes

⭐ Exciting Update: CINDERELLA Clinical Trial ⭐ We're thrilled to announce the release of the CINDERELLA Clinical Trial presentation video! Disclaimer: this video, created for educational purposes, offers a glimpse into our innovative trial. While it may not fully represent every participant's experience, it captures the essence of our research. 🎥 Watch the Video Here: https://lnkd.in/d75c7tq5 The CINDERELLA Clinical Trial evaluates an AI-based tool's impact on clinical decisions for breast cancer surgery and is divided into two study arms: • Control Arm: receives standard medical care and advice. • Intervention Arm: utilises the CINDERELLA APP alongside standard care. Both arms are crucial in understanding the APP's potential to enhance breast cancer care. We encourage everyone to view and share our video. Your support can positively impact countless lives and shape the future of digital healthcare. This study is ongoing at six clinical centres: A. Champalimaud Foundation - Lisbon, Portugal B. University Hospital Heidelberg (UKHD) - Heidelberg, Germany C. Ospedale San Raffaele - Milano, Italy D. Sheba Medical Center, Tel Hashomer - Ramat Gan, Israel E. Gdański Uniwersytet Medyczny (Medical University of Gdańsk) - Gdańsk, Poland F. Copernicus Mamma Centrum, Wojewodzkie Centrum Onkologii, Copernicus Podmiot Leczniczy - Gdańsk, Poland Maria João Cardoso Oreste Davide Gentilini Orit Kaidar-Person Maciej Bobowicz Paweł Kabata MD, PhD Prof. Dr. Timo Schinköthe Oriana Ciani Jaime Cardoso Marilia Antunes Giovani Silva Henrique Martins #JoergHeil SDA Bocconi CANKADO INESC TEC Centro de Estatística e Aplicações da Universidade de Lisboa #CINDERELLAProject #AIInHealthcare #DigitalHealthInnovation #horizoneu #BreastCancerAwareness #MakingADifference #breastcancer

Network Meta-analysis in Oncology and Cardiology fields. Wrote this article as a perspective, potentials and future considerations mostly. As i wrote so many practical R based tutorials in this field, felt the need to complement that with a perspective in Oncology and Cardiology Research. Here is the full article : https://lnkd.in/eSN-Nj8N #oncology #cardiology #metaanalysis #slr #systematic #review #datascience #biostatistics #stats

Wednesday, November 13, at noon, as part of our radiology research forum: "Image-Derived Disease Biomarkers in Breast Cancer and Lung Disease," with Gabrielle Baxter, PhD, who recently completed postdoctoral training at UCL. Talk details: https://lnkd.in/e46NTvCq #radiology #research #MRI in #BreastCancer and #LungDisease

👉 Grigorios Kalliatakis, FORTH, recently showcased the CARDIOCARE groundbreaking research at the 14th FORTH Scientific Retreat, held from October 11-13, 2024, in Ancient Olympia, Greece. The poster, titled “Deep Learning-based Automated Assessment of Reduced Left Ventricular Ejection Fraction by Echocardiography,” highlighted the potential of Artificial Intelligence to revolutionize the field of cardiology, particularly in the assessment of heart function via echocardiography. Really glad to have participated! 🔗 https://lnkd.in/df6mp_d3 . . . #cardiocareEUproject #cardiocare #cardiotoxicity #breastcancer #EUproject #EUfunded #H2020 #healthcare #BreastCancerAwareness #HeartHealth #ElderlyCare #Oncology #CardioOncology #research

📢 Call for Papers: Special Issue on Signaling Transduction Pathways in Oral Cancer Signaling transduction plays a critical role in cellular equilibrium and complex responses. This issue will explore the intricate signaling pathways that play a critical role in oral cancer, from extracellular signals to intracellular mechanisms. Understanding the roles of cytokines, chemokines, and other signaling molecules is essential for comprehending oral cancer progression and therapeutic resistance. We aim to provide comprehensive insights into these processes, potentially leading to breakthroughs in targeted therapies and personalized medicine. Guest Editors: 👨⚕️ I-Ta Lee, School of Dentistry, Taipei Medical University, Taiwan 👩⚕️ Thi Thuy Tien Vo, Faculty of Dentistry, Nguyen Tat Thanh University, Vietnam 🔗 Learn more and submit your research: https://lnkd.in/e8rHVRWz #OralCancer #SignalingPathways #CancerResearch #TargetedTherapies #PersonalizedMedicine #CallForPapers #OncologyResearch #TechSciencePress

Positive Data from IceCure Medical's Kidney Cancer Clinical Study Presented at Interventional Radiology Conference: Minimally Invasive Approach Results in Shorter Hospitalization and Minor Impact on Renal Function Data from the previously announced ICESECRET interim results were presented at the 3rd Annual Israeli Conference on #InterventionalRadiology by Dr. Avivit Shoham, Deputy Director of the Vascular and Interventional Radiology Unit at Beilinson - Rabin Medical Center on June 10. ICESECRET interim results demonstrated ProSense® #cryoablation to be safe and effective in treating kidney tumors with 89.5% recurrence-free rate. More data is expected in the fourth quarter of 2024. https://lnkd.in/dJNgYtZ8 Eyal Shamir Ronen Tsimerman Tlalit Bussi Tel-Tzure Naum Muchnik Galit (Bar) Malik Merav Nir Dotan Shay Levav Shad Good Hilla Debby Rafael Kaplan Mor Arieli🎗️ Michael Mejeninov #pressrelease #investorrelations $ICCM

📖 #SpecialIssue Announcement: New Challenges in Neuro-Oncology Special issue "New Challenges in Neuro-Oncology: From Diagnosis to Treatment," now open for submissions! This issue will explore the complexities of diagnosing and treating brain tumors, from cutting-edge imaging technologies to emerging therapies for high-grade gliomas, pediatric neuro-oncology, and metastatic CNS involvement. 🧬Key areas of focus include: -Advanced imaging, including PET-CT and MRI -Molecular targets and novel treatment strategies -New-generation therapies like TKIs, PARP-inhibitors, and immunotherapy -The evolving role of stereotactic radiotherapy for brain and spine tumors 📅 Submission Deadline: June 30, 2025 👥 Guest Editors: Dr. Francesco Cuccia, Dr. Giuseppe Ferrera, Dr. Giuseppe Carruba, Dr. Livio Blasi, Dr. Giuseppe Craparo (ARNAS Civico Hospital, Palermo, Italy) Be part of the future of neuro-oncology—submit your research here: https://lnkd.in/e6uU6WAX #CallforPapers #Glioblastoma #PediatricNeuroOncology #SpineTumors #Radiotherapy #Oncology #LowGradeGliomas #BrainTumors #NeuroOncology #OncologyResearch #TechSciencePress

Today (June 8th) is #WorldBrainTumorDay, a day dedicated to promoting education about brain tumors and honoring those affected by them. #BrainTumors can form in various brain or central nervous system regions, resulting in cognitive impairments and motor deficits. So far, in 2024, cancers of the brain or nervous system account for 1.3% of all new cancer cases. Not all brain tumors are malignant; approximately 72% are benign. The most common benign tumors are non-malignant #Meningiomas, while the most prevalent malignant tumors are #Glioblastomas. Together, these two types account for 53.9% of all brain tumors. Around the globe, we continue to research a cure for brain tumors and develop new treatment options. Current treatments include neurosurgery, radiation, chemotherapy, precision medicine, electrical field devices, and emerging therapies in clinical trials. On this special day, we rally support for the brain tumor community, raise awareness, advocate for research, and empower patients. #BrainTumorAwareness #BrainTumorSupport #BrainTumorAdvocacy